Characterization of contraction-inducible CXC chemokines and their roles in C2C12 myocytes.
Physical exercise triggers the release of several cytokines/chemokines from working skeletal muscles, but the underlying mechanism(s) by which skeletal muscles decipher and respond to highly complex contractile stimuli remains largely unknown. In an effort to investigate the regulatory mechanisms of the expressions of two contraction-inducible CXC chemokines, CXCL1/KC and CXCL5/LIX, in contracting skeletal muscle cells, we took advantage of our in vitro exercise model using highly developed contractile C(2)C(12) myotubes, which acquire properties similar to those of in vivo skeletal muscle via manipulation of Ca(2+) transients with electric pulse stimulation (EPS). Production of these CXC chemokines was immediately augmented by EPS-evoked contractile activity in a manner dependent on the activities of JNK and NF-kappaB, but not p38, ERK1/2, or calcineurin. Intriguingly, exposure of myotubes to cyclic mechanical stretch also induced expression of these CXC chemokines; however, a much longer period of stimulation (approximately 12 h) was required, despite rapid JNK phosphorylation. We also demonstrate herein that CXCL1/KC and CXCL5/LIX have the ability to raise intracellular Ca(2+) concentrations via CXCR2-mediated activation of pertussis toxin-sensitive Galpha(i) proteins in C(2)C(12) myoblasts, an action at least partially responsible for their migration and differentiation. Although we revealed a possible negative feedback regulation of their own production in response to the contractile activity in differentiated myotubes, exogenous administration of these CXC chemokines did not acutely influence either insulin-induced Akt phosphorylation or GLUT4 translocation in C(2)C(12) myotubes. Taken together, these data shed light on the fundamental characteristics of contraction-inducible CXC chemokine production and their potential roles in skeletal muscle cells.
Nedachi
Taku
T
Center for Research Strategy and Support (CRESS), Tohoku University, Sendai, Japan.
Hatakeyama
Hiroyasu
H
Kono
Tatsuyoshi
T
Sato
Masaaki
M
Kanzaki
Makoto
M
D000818:Animals; D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D002465:Cell Movement / Q000502:physiology; D054360:Chemokine CXCL1 / Q000235:genetics / Q000378:metabolism; D054365:Chemokine CXCL5 / Q000235:genetics / Q000378:metabolism; D019743:Chemokines, CXC / Q000096:biosynthesis / Q000502:physiology*; D004558:Electric Stimulation; D004797:Enzyme-Linked Immunosorbent Assay; D008465:Mechanoreceptors / Q000502:physiology; D051379:Mice; D009119:Muscle Contraction / Q000502:physiology*; D018485:Muscle Fibers, Skeletal / Q000378:metabolism / Q000502:physiology*; D032446:Myoblasts / Q000502:physiology; D016328:NF-kappa B / Q000378:metabolism; D010812:Physical Stimulation; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
D054360:Chemokine CXCL1; D054365:Chemokine CXCL5; D019743:Chemokines, CXC; C475895:Cxcl1 protein, mouse; C094739:Cxcl5 protein, mouse; D016328:NF-kappa B; D016271:Proto-Oncogene Proteins c-myc; D012313:RNA; D002118:Calcium